Illumina Inc. v. BGI Genomics Co., Ltd.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ILLUMINA INC., et al., Case No. 20-cv-01465-WHO

Plaintiffs,

ORDER GRANTING IN PART AND

v. DENYING IN PART MOTION FOR

PARTIAL SUMMARY JUDGMENT

BGI GENOMICS CO., LTD., et al., Re: Dkt. Nos. 408, 409, 419 Defendants.

12 Defendants BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc., and Complete Genomics, Inc.’s (collectively, “BGI”) move for partial summary judgment on Plaintiffs Illumina Inc. and Illumina Cambridge Ltd. (collectively, “Illumina”) complaint. BGI asserts that Illumina’s U.S. Patent No. 7,777,973 (“’973 Patent”) is invalid for failure to satisfy the enablement and written description requirements under 35 U.S.C. § 112 and that its accused product does not infringe Illumina’s U.S. Patent No. 10,480,025 (“’025 Patent”). For the reasons below, BGI’s motion for summary judgment on the invalidity of the ’973 Patent is DENIED. BGI’s motion for summary judgment on the CoolMPS products’ non-infringement of…